Omeros

Launch date

1994

Employees

Market cap

Enterprise valuation

AUD418m (Public information from Sep 2024)

Charlottesville Virginia (HQ)

http://www.omeros.com

https://twitter.com/omeroscorp https://www.linkedin.com/company/omeros-corporation/

View job openings

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	73.8m	-	-	123m	6.0m	8.0m	25.5m
% growth	(34 %)	-	-	-	(95 %)	33 %	219 %
EBITDA	(110m)	(172m)	(159m)	(151m)	(166m)	(152m)	-
% EBITDA margin	(149 %)	-	-	(123 %)	(2767 %)	(1900 %)	-
Profit	(138m)	194m	47.4m	(147m)	(176m)	(156m)	(134m)
% profit margin	(187 %)	-	-	(120 %)	(2930 %)	(1954 %)	(527 %)
EV / revenue	15.0x	-	-	1.7x	40.7x	30.5x	9.6x
EV / EBITDA	-10.1x	-3.4x	-1.8x	-1.4x	-1.5x	-1.6x	-
R&D budget	111m	119m	113m	-	-	-	-
R&D % of revenue	150 %	-	-	-	-	-	-

Source: Dealroom estimates

Date	Investors	Amount	Round
-	Aravis Ventures Trevi Health Ventures Stanley Medical Research Institute The Grosvenor Funds Southern Cross Venture Partners ARCH Venture Partners Novartis Venture Fund	N/A	-
Mar 2014	N/A	AUD37.8m	Post IPO Equity
Mar 2015	Midcap Financial Oxford Finance	AUD32.0m	Post IPO Debt
Jan 2016*	East West Bank Oxford Finance	$70.0m	Post IPO Debt
May 2016	East West Bank Oxford Finance	$20.0m	Post IPO Debt
Nov 2016	CRG LP	$125m	Post IPO Debt
Aug 2017	N/A	$68.0m	Post IPO Equity
Nov 2018*	N/A	$210m	Post IPO Debt
Dec 2019*	N/A	N/A	Post IPO Equity
Aug 2020*	N/A	$100m	Post IPO Equity
Apr 2023*	National Institute on Drug Abuse	$6.7m	Grant
Total Funding		AUD126m

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by Omeros Sep 2006